SleepNCT07183735
A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance
A study testing BEAM Dream Powder in people with Sleep and Sleep Disorder, run by Beam at 1 site in United States.
Trial summary
This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Sleep, Sleep Disorder
- What is being tested?
- BEAM Dream Powder
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 2 Jul 2024to 17 Oct 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Male or female
- 18+ years old
- Self-reported issues with sleeping, falling asleep, or staying asleep.
- Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration.
- Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial.
- Willing to maintain their standard sleep pattern and activity level for the duration of the study.
- Be generally healthy and not live with any uncontrolled chronic disease.
Who cannot join
- Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea.
- Women who are pregnant, breastfeeding, or trying to conceive.
- Anyone unwilling or unable to follow the study protocol.
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Is currently undergoing, or planning to undergo, any significant medical procedures during the study period.
- Has undergone any surgeries or invasive treatments in the last six months.
Show all 12Show fewer
- A history of severe allergic reactions, including but not limited to any of the product's ingredients.
- Anyone with a nut allergy.
- Heavy drinkers. A heavy drinker is considered to be a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week.
- Anyone who uses illicit drugs.
- Use any prescription medication, over-the-counter, or herbal remedies that can affect sleep.
- Have a job that involves working the third or night shifts.
Trial locations and contacts
1 site in 1 country.
About this study
This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.
- Conditions
- Sleep, Sleep Disorder
- Being tested
- BEAM Dream Powder, Placebo Control
- Keywords
- Sleep Quality
- Medical subject headings
- Sleep Wake Disorders, Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BEAM Dream PowderDietary supplement
A powdered sleep supplement. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 3-6.
Placebo ControlDietary supplement
A powdered placebo product. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 1-2.
| Study group | Role | What they receive |
|---|---|---|
| BEAM Dream Powder | Experimental | Not described Receives: Dietary Supplement: BEAM Dream Powder |
| Placebo | Placebo comparator | Not described Receives: Dietary Supplement: Placebo Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in sleep quality as measured by the Sleep Quality Scale (SQS)
Sleep quality will be assessed using the self-reported Sleep Quality Scale (SQS), a validated questionnaire evaluating subjective sleep quality.
Measured: Baseline, Week 2, Week 4, Week 6
Change in sleep quantity and architecture as measured by sleep tracker
Objective sleep metrics (e.g., time to fall asleep, deep sleep, REM sleep, sleep transitions, sleep duration, and frequency of waking) will be collected using a sleep tracking device.
Measured: Baseline, Week 2, Week 4, Week 6
Secondary outcomes (5)
Change in perceived restfulness as measured by self-reported questionnaire
Participants will report perceived restfulness levels to assess subjective recovery and rest post-intervention.
Measured: Baseline, Week 2, Week 4, Week 6
Change in overall energy levels as measured by self-reported questionnaire
Participants will rate their energy levels using a structured questionnaire.
Measured: Baseline, Week 2, Week 4, Week 6
Change in emotional well-being as measured by self-reported questionnaire
Emotional well-being will be assessed using a validated self-report measure.
Measured: Baseline, Week 2, Week 4, Week 6
Change in cognitive function as measured by self-reported questionnaire
Cognitive function will be assessed through a participant questionnaire evaluating attention, memory, and mental clarity.
Measured: Baseline, Week 2, Week 4, Week 6
Change in dietary behavior (e.g., hunger levels) as measured by self-reported questionnaire
Participants will report perceived hunger levels and related dietary behavior using a structured questionnaire.
Measured: Baseline, Week 2, Week 4, Week 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2025
- Study start2 Jul 2024
- Primary completion17 Oct 2024
- Study completion17 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SleepStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beam
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07183735
- Sponsor's protocol ID
- 20417
- Status last verified
- Sep 2025
- First submitted
- 7 Aug 2025
- Last updated
- 19 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance
- ClinicalTrials.gov ID
- NCT07183735
- Acronym / sponsor ID
- 20417
- Conditions
- Sleep, Sleep Disorder
- Keywords
- Sleep Quality
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- BeamIndustry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 2 Jul 2024 (actual)
- Primary completion
- 17 Oct 2024 (actual)
- Study completion
- 17 Oct 2024 (actual)
- First posted
- 19 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| BEAM Dream Powder | Experimental | Dietary Supplement: BEAM Dream Powder |
| Placebo | Placebo comparator | Dietary Supplement: Placebo Control |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Male or female
- 18+ years old
- Self-reported issues with sleeping, falling asleep, or staying asleep.
- Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration.
- Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial.
Key exclusion criteria (12 listed)
- Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea.
- Women who are pregnant, breastfeeding, or trying to conceive.
- Anyone unwilling or unable to follow the study protocol.
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Is currently undergoing, or planning to undergo, any significant medical procedures during the study period.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BEAM Dream PowderA powdered sleep supplement. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 3-6. | Dietary supplement | BEAM Dream Powder |
| Placebo ControlA powdered placebo product. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 1-2. | Dietary supplement | Placebo |
Primary outcome
Change in sleep quality as measured by the Sleep Quality Scale (SQS)
Time frame: Baseline, Week 2, Week 4, Week 6
Sleep quality will be assessed using the self-reported Sleep Quality Scale (SQS), a validated questionnaire evaluating subjective sleep quality.
Change in sleep quantity and architecture as measured by sleep tracker
Time frame: Baseline, Week 2, Week 4, Week 6
Objective sleep metrics (e.g., time to fall asleep, deep sleep, REM sleep, sleep transitions, sleep duration, and frequency of waking) will be collected using a sleep tracking device.
5 secondary outcomes
Change in perceived restfulness as measured by self-reported questionnaire
Time frame: Baseline, Week 2, Week 4, Week 6
Change in overall energy levels as measured by self-reported questionnaire
Time frame: Baseline, Week 2, Week 4, Week 6
Change in emotional well-being as measured by self-reported questionnaire
Time frame: Baseline, Week 2, Week 4, Week 6
Change in cognitive function as measured by self-reported questionnaire
Time frame: Baseline, Week 2, Week 4, Week 6
Change in dietary behavior (e.g., hunger levels) as measured by self-reported questionnaire
Time frame: Baseline, Week 2, Week 4, Week 6
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2025.
Related trials for Sleep
Recruiting
NightWare and Cardiovascular Health in Women With PTSD
Post Traumatic Stress Disorder, Cardiovascular Diseases
Recruiting
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness
Nocturia, Insomnia
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Recruiting
Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
Histamine, Cowhage
Not yet recruiting
REM Enhancement Sleep Technology for Well-being, Emotion, and Life Lift
Healthy Adult Participants
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BEAM Dream Powder in people with Sleep and Sleep Disorder, run by Beam at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in sleep quality as measured by the Sleep Quality Scale (SQS) (time frame: Baseline, Week 2, Week 4, Week 6). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025.